Viewing Study NCT02171156


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-02-21 @ 11:36 PM
Study NCT ID: NCT02171156
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2017-05-08
First Post: 2014-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module